Enzyre

Nijmegen, The Netherlands

Enzyre is a developer of diagnostic technology.

$11.8M raised

Nov 2022

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Enzyre raised?

Enzyre has raised $11.8M in total funding. The most recent round was Series A. The last funding was announced in November 2022.

Who are Enzyre's investors?

Enzyre's investors include Novalis Biotechnology Incubation, i&i Biotech Fund, OostNL, Demcon, Takeda Ventures.

Where is Enzyre headquartered?

Enzyre is headquartered in Nijmegen, The Netherlands.

What does Enzyre do?

Enzyre is a developer of diagnostic technology.

What stage is Enzyre at?

Enzyre is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 2, 2022.

MLA

"Enzyre — Funding & Investors." VCBacked, November 2, 2022, https://www.vcbacked.co/company/enzyre. Accessed July 2, 2026.

APA

VCBacked. (2022). Enzyre — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/enzyre

Wikipedia (cite web)

{{cite web |title=Enzyre — Funding & Investors |url=https://www.vcbacked.co/company/enzyre |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 2, 2022.